BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8555511)

  • 1. Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+.
    Chan JK; Tsang WY; Ng CS
    Blood; 1996 Jan; 87(2):839-41. PubMed ID: 8555511
    [No Abstract]   [Full Text] [Related]  

  • 2. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
    Kato N; Yasukawa K; Onozuka T; Kikuta H
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR-CD56+CD2+ nasal lymphomas with membrane-localized CD3 positivity: are the CD3+ cells neoplastic or reactive?
    Tao Q; Chiang AK; Srivastava G; Ho FC
    Blood; 1995 May; 85(10):2993-6. PubMed ID: 7537987
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
    Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
    Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56-negative extranodal nasal type of natural killer/T-cell lymphoma with extranasal skin involvement.
    Lan MX; Zhen ZX; Ming WH
    Leuk Lymphoma; 2009 Oct; 50(10):1715-7. PubMed ID: 19863343
    [No Abstract]   [Full Text] [Related]  

  • 6. CD56 lymphomas.
    Emile JF; Gaulard P
    Am J Surg Pathol; 1996 Feb; 20(2):252-3. PubMed ID: 8554118
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
    Mori N; Yatabe Y; Oka K; Kinoshita T; Kobayashi T; Ono T; Asai J
    Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections.
    Chan JK; Tsang WY; Pau MY
    Hum Pathol; 1995 Oct; 26(10):1139-43. PubMed ID: 7557948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance.
    Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R
    Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas.
    Suzumiya J; Takeshita M; Kimura N; Kikuchi M; Uchida T; Hisano S; Eura Y; Kozuru M; Nomura Y; Tomita K
    Blood; 1994 Apr; 83(8):2255-60. PubMed ID: 8161791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD56 (NCAM)-positive malignant lymphoma.
    Wong KF; Chan JK; Ng CS
    Leuk Lymphoma; 1994 Jun; 14(1-2):29-36. PubMed ID: 7522719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteropathy-type T-cell lymphoma expressing NK-cell intraepithelial lymphocyte (NK-IEL) phenotype.
    Inagaki N; Asaoka D; Mori KL; Sohda N; Miura I; Miwa H; Sato N; Oshimi K
    Leuk Lymphoma; 2004 Jul; 45(7):1471-4. PubMed ID: 15359651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometry characterization of leukemic phase of nasal NK/T-cell lymphoma in tumor biopsies and peripheral blood.
    Falcão RP; Rizzatti EG; Saggioro FP; Garcia AB; Marinato AF; Rego EM
    Haematologica; 2007 Feb; 92(2):e24-5. PubMed ID: 17405750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56+ NK lymphomas: clinicopathological features and prognosis.
    Kwong YL; Chan AC; Liang R; Chiang AK; Chim CS; Chan TK; Todd D; Ho FC
    Br J Haematol; 1997 Jun; 97(4):821-9. PubMed ID: 9217183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype.
    Chan JK; Tsang WY
    Cancer; 1995 Aug; 76(3):537-8. PubMed ID: 8625143
    [No Abstract]   [Full Text] [Related]  

  • 16. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm.
    Nakamura F; Tatsumi E; Kawano S; Tani A; Kumagai S; Nishikori M; Nagai T
    Blood; 1997 Jun; 89(12):4665-6. PubMed ID: 9192799
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
    Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
    J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoproliferative disorders of natural killer cells.
    Oshimi K
    Int J Hematol; 1996 Jun; 63(4):279-90. PubMed ID: 8762811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematodermic CD4/CD56 neoplasm].
    Petrella T; Wechsler J; Courville P; de Muret A; Bosq J; Déchelotte P; Feuillard J; Durlach A; Vergier B
    Ann Pathol; 2004 Jun; 24(3):241-55; quiz 227. PubMed ID: 15480259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.